SlideShare a Scribd company logo
1 of 14
MICROCYTOTOXICITY
   ( microlymphocytotoxicity)
Complement Dependent Cytotoxicity
             (CDC)

           By Dr Rania Abo-Shady
     Ass. Professor of Clinical Pathology
   Ain Shams University Fac. of Medicine
HLA - Typing
SEROLOGY used to be the ‘gold’ standard. Now being
superseded by molecular techniques as they become
more robust and time efficient.


CELLULAR rarely used now. Originally used for Class
II typing.


MOLECULAR fast becoming the method of choice.
Many laboratories test of choice.
SEROLOGY
HLA Typing is done serologically by MICROCYTOTOXICITY
which tests for complement mediated lysis of
peripheral blood lymphocytes with a standard set of
typing sera.
Micro-cytotoxicity assay, utilizes serum with known
anti-HLA antibodies that recognize particular HLA loci
(HLA-A, HLA-B, HLA-C, HLA-DQ, HLA-DR /not DP) in
order to match genetically similar individuals in hopes
of performing a tissue transplantation.

Viable peripheral blood lymphocytes are obtained by
density gradient centrifugation using Ficoll at 19º- 22ºC.
Cell isolation:
 -For HLA Class I typing:
A mixture of T and B lymphocytes can be used by
lymphocyte separation .
 -For HLA Class II typing:
B lymphocytes are required. (Normal population 85-
90% T and 10-15% B cells)
This can be achieved using a number of methods:
 *Magnetic beads
Immunomagnetic bead separation is the current method of
choice.It utilises polystyrene microspheres with a magnetisable
core coated in monoclonal antibody for a HLA Class II b chain
monomorphic epitope. Positive selection.
 *Nylon wool
  In the past neuraminidase treated sheep red blood cell rosetting
and nylon wool have been used.
Coated with anti CD19
     for B cells
complement-dependent cytotoxicity
             (CDC)
Lymphocytes are HLA-typed by crossmatching to panel
 reactive antibodies (PRA) using the complement-
 dependent cytotoxicity (CDC) test.
                                              Complement
                                              antibody



                         Positive reaction to antibody
                         kills cells. Dead cells pick up dye.



       Buffy coat        Negative reaction to antibody:
       from patient      cells survive and exclude dye.
Principle of Microlymphocytotoxic test
 Microlymphocytotoxic test: 3 stages
• 1.Viable lymphocytes are incubated with HLA
  specific antibodies. If the specific antigen is present
  on the cell the antibody is bound.

• 2.Rabbit serum as a source of complement is added,
  incubate. If antibody is bound to the HLA antigen on
  the cell surface it activates the complement which
  damages the cell membrane making it permeable to
  vital stains.

• 3.Results are visualised by adding dye usually a
  fluorochrome eg Ethidium Bromide although Eosin
  Y have been used in the past.
Cells are prelabelled with Fluorochrome before
plating :
 when cells are killed +ve test ,fluorescine leaks
out and a second fluorochrome a ethidium
bromide is added to visualize dead cells.( double
staining can be used by using a cocktail of
Ethidium Bromide and Acridine Orange)

If the reaction has taken place the EB or Eosin
enters the cell and binds to the DNA.

Test is left for 10 minutes and then read using an
inverted fluorescent microscope.
Terazaki plate and inverted microscopy
Negative (living cells)   Positive (dead cells)
The percentage of stained cells
in each well is used to
determine whether the cells
are positive or negative for the   Positive   Negative

HLA antigen.
The Score Values in Lymphocytotoxicity Test (Terasaki and McClelland, 1964)




         The percentage of
                                Score                 Evaluation
             dead cells


               0-10              1                     Negative

               11-20             2             doubtful positive/Negative

               21-50             4                 Weak Positive(++)

               51-80             6                   Positive(+++)

              81-100             8               Strong positive(++++)


    The number of dead (lysed) lymphocytes was compared
    with the total number of cells quoted as score values
Advantages:
• Easily performed does not require expensive
  equipment.
• Takes around three hours to perform
• Low level resolution, with good antisera
  gives reliable results

Disadvantages:
• Requires large volumes of blood
• Requires viable lymphocytes
• Difficult to find good antisera for rarer
   antigens in different populations
Microcytotoxicity

More Related Content

What's hot

Histocompatability testiing
Histocompatability testiingHistocompatability testiing
Histocompatability testiingPriya Kamat
 
Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604deepak deshkar
 
02.13.09(b): T-Cell Development
02.13.09(b): T-Cell Development02.13.09(b): T-Cell Development
02.13.09(b): T-Cell DevelopmentOpen.Michigan
 
Hla transplantation and complement
Hla transplantation and complementHla transplantation and complement
Hla transplantation and complementYahya Noori, Ph.D
 
Antibody class switch ppt
Antibody class switch pptAntibody class switch ppt
Antibody class switch pptCHARLIE
 
B cell Activation by T Independent & T Dependent Antigens-Dr C R Meera
B cell Activation by T Independent & T Dependent Antigens-Dr C R MeeraB cell Activation by T Independent & T Dependent Antigens-Dr C R Meera
B cell Activation by T Independent & T Dependent Antigens-Dr C R MeeraMeera C R
 
HLA system and major histocompatibility complex
HLA system and major histocompatibility complexHLA system and major histocompatibility complex
HLA system and major histocompatibility complexSoujanya Pharm.D
 
ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)Suraj Dhara
 
Tumour immunology leture notes
Tumour immunology leture notesTumour immunology leture notes
Tumour immunology leture notesBruno Mmassy
 

What's hot (20)

Cytokines
CytokinesCytokines
Cytokines
 
Histocompatability testiing
Histocompatability testiingHistocompatability testiing
Histocompatability testiing
 
T-cell
T-cellT-cell
T-cell
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604Hla typi ng pg seminar final 0604
Hla typi ng pg seminar final 0604
 
02.13.09(b): T-Cell Development
02.13.09(b): T-Cell Development02.13.09(b): T-Cell Development
02.13.09(b): T-Cell Development
 
Hla transplantation and complement
Hla transplantation and complementHla transplantation and complement
Hla transplantation and complement
 
B cell activation and antibody production
B cell activation and antibody productionB cell activation and antibody production
B cell activation and antibody production
 
Antibody class switch ppt
Antibody class switch pptAntibody class switch ppt
Antibody class switch ppt
 
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
 
B cell Activation by T Independent & T Dependent Antigens-Dr C R Meera
B cell Activation by T Independent & T Dependent Antigens-Dr C R MeeraB cell Activation by T Independent & T Dependent Antigens-Dr C R Meera
B cell Activation by T Independent & T Dependent Antigens-Dr C R Meera
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Complement fixation tests
Complement fixation testsComplement fixation tests
Complement fixation tests
 
HLA system and major histocompatibility complex
HLA system and major histocompatibility complexHLA system and major histocompatibility complex
HLA system and major histocompatibility complex
 
ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Immune tolerance
Immune toleranceImmune tolerance
Immune tolerance
 
Antigen
AntigenAntigen
Antigen
 
Tumour immunology leture notes
Tumour immunology leture notesTumour immunology leture notes
Tumour immunology leture notes
 
MHC
MHC MHC
MHC
 

Similar to Microcytotoxicity

TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptx
TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptxTRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptx
TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptxBharath S R
 
Ezhil1[1][1].Ppt
Ezhil1[1][1].PptEzhil1[1][1].Ppt
Ezhil1[1][1].Pptelangoelil
 
Flow cytometry in diagnostics
Flow cytometry in diagnosticsFlow cytometry in diagnostics
Flow cytometry in diagnosticsKaberi Nath
 
JoeH47PosterFinalDraft
JoeH47PosterFinalDraftJoeH47PosterFinalDraft
JoeH47PosterFinalDraftJoe Rovinsky
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Monoclonal antibodies production(1)
Monoclonal antibodies production(1)Monoclonal antibodies production(1)
Monoclonal antibodies production(1)Yenda Manishankar
 
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityStrategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityCellero
 
Transplantation in sensitized patients(seminar)
Transplantation in sensitized patients(seminar)Transplantation in sensitized patients(seminar)
Transplantation in sensitized patients(seminar)Vishal Golay
 
Lecture5(6)
Lecture5(6)Lecture5(6)
Lecture5(6)dream10f
 

Similar to Microcytotoxicity (20)

Flow cytometry
Flow cytometryFlow cytometry
Flow cytometry
 
TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptx
TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptxTRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptx
TRANSPLANTATION IMMUNOLOGY- MLR, HLA TYPING.pptx
 
TISSUE TYPING .pptx
TISSUE TYPING                       .pptxTISSUE TYPING                       .pptx
TISSUE TYPING .pptx
 
Ezhil1
Ezhil1Ezhil1
Ezhil1
 
sehras.pptx
sehras.pptxsehras.pptx
sehras.pptx
 
Transplantation
Transplantation Transplantation
Transplantation
 
Ezhil1.Ppt
Ezhil1.PptEzhil1.Ppt
Ezhil1.Ppt
 
Ezhil1
Ezhil1Ezhil1
Ezhil1
 
Ezhil1[1][1].Ppt
Ezhil1[1][1].PptEzhil1[1][1].Ppt
Ezhil1[1][1].Ppt
 
Flow cytometry in diagnostics
Flow cytometry in diagnosticsFlow cytometry in diagnostics
Flow cytometry in diagnostics
 
JoeH47PosterFinalDraft
JoeH47PosterFinalDraftJoeH47PosterFinalDraft
JoeH47PosterFinalDraft
 
Transplantation
TransplantationTransplantation
Transplantation
 
Methods of immunosuppression
Methods of immunosuppressionMethods of immunosuppression
Methods of immunosuppression
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Complement Dependent Cytotoxicity (CDC) cross match test
Complement Dependent Cytotoxicity (CDC) cross match testComplement Dependent Cytotoxicity (CDC) cross match test
Complement Dependent Cytotoxicity (CDC) cross match test
 
Monoclonal antibodies production(1)
Monoclonal antibodies production(1)Monoclonal antibodies production(1)
Monoclonal antibodies production(1)
 
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated CytotoxicityStrategies for Accurately Measuring Cell-Mediated Cytotoxicity
Strategies for Accurately Measuring Cell-Mediated Cytotoxicity
 
Transplantation in sensitized patients(seminar)
Transplantation in sensitized patients(seminar)Transplantation in sensitized patients(seminar)
Transplantation in sensitized patients(seminar)
 
Lecture5(6)
Lecture5(6)Lecture5(6)
Lecture5(6)
 

Microcytotoxicity

  • 1. MICROCYTOTOXICITY ( microlymphocytotoxicity) Complement Dependent Cytotoxicity (CDC) By Dr Rania Abo-Shady Ass. Professor of Clinical Pathology Ain Shams University Fac. of Medicine
  • 2. HLA - Typing SEROLOGY used to be the ‘gold’ standard. Now being superseded by molecular techniques as they become more robust and time efficient. CELLULAR rarely used now. Originally used for Class II typing. MOLECULAR fast becoming the method of choice. Many laboratories test of choice.
  • 3. SEROLOGY HLA Typing is done serologically by MICROCYTOTOXICITY which tests for complement mediated lysis of peripheral blood lymphocytes with a standard set of typing sera. Micro-cytotoxicity assay, utilizes serum with known anti-HLA antibodies that recognize particular HLA loci (HLA-A, HLA-B, HLA-C, HLA-DQ, HLA-DR /not DP) in order to match genetically similar individuals in hopes of performing a tissue transplantation. Viable peripheral blood lymphocytes are obtained by density gradient centrifugation using Ficoll at 19º- 22ºC.
  • 4. Cell isolation: -For HLA Class I typing: A mixture of T and B lymphocytes can be used by lymphocyte separation . -For HLA Class II typing: B lymphocytes are required. (Normal population 85- 90% T and 10-15% B cells) This can be achieved using a number of methods: *Magnetic beads Immunomagnetic bead separation is the current method of choice.It utilises polystyrene microspheres with a magnetisable core coated in monoclonal antibody for a HLA Class II b chain monomorphic epitope. Positive selection. *Nylon wool In the past neuraminidase treated sheep red blood cell rosetting and nylon wool have been used.
  • 5. Coated with anti CD19 for B cells
  • 6. complement-dependent cytotoxicity (CDC) Lymphocytes are HLA-typed by crossmatching to panel reactive antibodies (PRA) using the complement- dependent cytotoxicity (CDC) test. Complement antibody Positive reaction to antibody kills cells. Dead cells pick up dye. Buffy coat Negative reaction to antibody: from patient cells survive and exclude dye.
  • 7. Principle of Microlymphocytotoxic test Microlymphocytotoxic test: 3 stages • 1.Viable lymphocytes are incubated with HLA specific antibodies. If the specific antigen is present on the cell the antibody is bound. • 2.Rabbit serum as a source of complement is added, incubate. If antibody is bound to the HLA antigen on the cell surface it activates the complement which damages the cell membrane making it permeable to vital stains. • 3.Results are visualised by adding dye usually a fluorochrome eg Ethidium Bromide although Eosin Y have been used in the past.
  • 8. Cells are prelabelled with Fluorochrome before plating : when cells are killed +ve test ,fluorescine leaks out and a second fluorochrome a ethidium bromide is added to visualize dead cells.( double staining can be used by using a cocktail of Ethidium Bromide and Acridine Orange) If the reaction has taken place the EB or Eosin enters the cell and binds to the DNA. Test is left for 10 minutes and then read using an inverted fluorescent microscope.
  • 9. Terazaki plate and inverted microscopy
  • 10. Negative (living cells) Positive (dead cells)
  • 11. The percentage of stained cells in each well is used to determine whether the cells are positive or negative for the Positive Negative HLA antigen.
  • 12. The Score Values in Lymphocytotoxicity Test (Terasaki and McClelland, 1964) The percentage of Score Evaluation dead cells 0-10 1 Negative 11-20 2 doubtful positive/Negative 21-50 4 Weak Positive(++) 51-80 6 Positive(+++) 81-100 8 Strong positive(++++) The number of dead (lysed) lymphocytes was compared with the total number of cells quoted as score values
  • 13. Advantages: • Easily performed does not require expensive equipment. • Takes around three hours to perform • Low level resolution, with good antisera gives reliable results Disadvantages: • Requires large volumes of blood • Requires viable lymphocytes • Difficult to find good antisera for rarer antigens in different populations